CV3 COST-EFFECTIVENESS OF RIVAROXABAN VERSUS ENOXAPARIN FOR PREVENTION OF VENOUS THROMBOEMBOLISM (VTE) AFTER TOTAL KNEE REPLACEMENT (TKR) IN CHINA

Nov 1, 2010, 00:00
10.1016/S1098-3015(11)73076-5
https://www.valueinhealthjournal.com/article/S1098-3015(11)73076-5/fulltext
Title : CV3 COST-EFFECTIVENESS OF RIVAROXABAN VERSUS ENOXAPARIN FOR PREVENTION OF VENOUS THROMBOEMBOLISM (VTE) AFTER TOTAL KNEE REPLACEMENT (TKR) IN CHINA
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)73076-5&doi=10.1016/S1098-3015(11)73076-5
First page : A506
Section Title : RESEARCH PODIUM ABSTRACTS
Open access? : No
Section Order : 1234
Categories :
Tags :
Regions :
ViH Article Tags :